NewEdge Advisors’s SunLink Health Systems SSY Stock Holding History

NewEdge Advisors’s Portfolio SSY Stock Details SSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25	Closed	-$25	–	4145
2025 Q1	$25	Hold	25	–	–	﹤0.01%	3883
2024 Q4	$22	Buy	+25	New	+$21	﹤0.01%	3848

Other funds holding SSY

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

WIM

Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

NewEdge Advisors's SSY Position: Q2 2025 in Review

NewEdge Advisors sold out of SunLink Health Systems (SSY) in Q2 2025, closing a stake of 25 shares — an estimated $25 sold.

NewEdge Advisors first reported a position in SSY in Q4 2024 and held it in 2 quarters. The position peaked at $25 in Q1 2025. 17 funds tracked by Wall St. Rank hold SSY as of Q2 2025.

NewEdge Advisors reported no remaining SunLink Health Systems position as of Q2 2025 after selling out during the quarter.
NewEdge Advisors sold 25 SunLink Health Systems shares in Q2 2025, an estimated $25.
NewEdge Advisors first reported a position in SunLink Health Systems in Q4 2024 and held it in 2 quarters.
NewEdge Advisors's SunLink Health Systems position peaked at $25 in Q1 2025.
17 funds tracked by Wall St. Rank held SunLink Health Systems as of Q2 2025.

Based on NewEdge Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.